The first adjustable, fully visible stent retriever shows superiority over conventional stent retrievers in a multicenter trial. The late-breaking results were recently presented at the International Stroke Conference and published online in the journal Stroke.
5/16/18: "We are pleased to have enrolled the first patients and to have a leadership role in the TIGER study. Stentrievers are now the gold standard for treating ischemic stroke, and TIGERTRIEVER is a new generation stentriever. Its unique design will hopefully show that it addresses the limitations of current devices and will improve patient outcomes," stated Dr. Rishi Gupta.